Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169261617> ?p ?o ?g. }
- W2169261617 abstract "Prostate-specific antigen (PSA) nadir + 2 ng/mL, also known as the Phoenix definition, is the definition most commonly used to establish biochemical failure (BF) after external beam radiotherapy for prostate cancer management. The purpose of this study is to compare BF rates between permanent prostate brachytherapy (PPB) and radical retropubic prostatectomy (RRP) as a function of PSA nadir plus varying values of X and examine the associated implications. We retrospectively searched for patients who underwent PPB or RRP at our institution between 1998 and 2004. Only primary patients not receiving androgen-deprivation therapy were included in the study. Three RRP patients were matched to each PPB patient on the basis of prognostic factors. BF rates were estimated for PSA nadirs + different values of X. A total of 1,164 patients were used for analysis: 873 in the RRP group and 291 in the PPB group. Patients were equally matched by clinical stage, biopsy Gleason sum, primary Gleason grade, and pretherapy PSA value. Median follow-up was 3.1 years for RRP patients and 3.6 years in the PPB group (P = .01). Using PSA nadir + 0.1 ng/mL for the definition of BF, the 5-year BF rate was 16.3% for PPB patients and 13.5% for RRP patients (P = .007), whereas at nadir + 2 ng/mL or greater, the BF rates were less than 3% and were indistinguishable between PPB and RRP patients. In a cohort of well-matched patients who had prostatectomy or brachytherapy, we examined BF as a function of nadir + X, where X was treated as a continuous variable. As X increases from 0.1 to 2.0 ng/mL, the BF curves converge, and above 2.0 ng/mL they are essentially indistinguishable. The data presented are of interest as BF definitions continue to evolve." @default.
- W2169261617 created "2016-06-24" @default.
- W2169261617 creator A5019320597 @default.
- W2169261617 creator A5040586351 @default.
- W2169261617 creator A5043214875 @default.
- W2169261617 creator A5062598853 @default.
- W2169261617 creator A5065219412 @default.
- W2169261617 creator A5082993331 @default.
- W2169261617 creator A5090902762 @default.
- W2169261617 date "2014-07-29" @default.
- W2169261617 modified "2023-10-18" @default.
- W2169261617 title "Comparison of biochemical failure rates between permanent prostate brachytherapy and radical retropubic prostatectomy as a function of posttherapy PSA nadir plus ‘X’" @default.
- W2169261617 cites W1969931964 @default.
- W2169261617 cites W1978415948 @default.
- W2169261617 cites W1981695099 @default.
- W2169261617 cites W1987213359 @default.
- W2169261617 cites W1994482727 @default.
- W2169261617 cites W2000377697 @default.
- W2169261617 cites W2007072795 @default.
- W2169261617 cites W2022266950 @default.
- W2169261617 cites W2026566205 @default.
- W2169261617 cites W2028639699 @default.
- W2169261617 cites W2030479253 @default.
- W2169261617 cites W2040103703 @default.
- W2169261617 cites W2041230820 @default.
- W2169261617 cites W2053198390 @default.
- W2169261617 cites W2059042946 @default.
- W2169261617 cites W2061988762 @default.
- W2169261617 cites W2093867637 @default.
- W2169261617 cites W2100001148 @default.
- W2169261617 cites W2111858931 @default.
- W2169261617 cites W2117792530 @default.
- W2169261617 cites W2128289067 @default.
- W2169261617 cites W2133199470 @default.
- W2169261617 cites W2140023635 @default.
- W2169261617 cites W2140680429 @default.
- W2169261617 cites W2142470634 @default.
- W2169261617 cites W2408071343 @default.
- W2169261617 doi "https://doi.org/10.1186/1748-717x-9-171" @default.
- W2169261617 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4123307" @default.
- W2169261617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25074478" @default.
- W2169261617 hasPublicationYear "2014" @default.
- W2169261617 type Work @default.
- W2169261617 sameAs 2169261617 @default.
- W2169261617 citedByCount "4" @default.
- W2169261617 countsByYear W21692616172016 @default.
- W2169261617 countsByYear W21692616172020 @default.
- W2169261617 countsByYear W21692616172021 @default.
- W2169261617 crossrefType "journal-article" @default.
- W2169261617 hasAuthorship W2169261617A5019320597 @default.
- W2169261617 hasAuthorship W2169261617A5040586351 @default.
- W2169261617 hasAuthorship W2169261617A5043214875 @default.
- W2169261617 hasAuthorship W2169261617A5062598853 @default.
- W2169261617 hasAuthorship W2169261617A5065219412 @default.
- W2169261617 hasAuthorship W2169261617A5082993331 @default.
- W2169261617 hasAuthorship W2169261617A5090902762 @default.
- W2169261617 hasBestOaLocation W21692616171 @default.
- W2169261617 hasConcept C121608353 @default.
- W2169261617 hasConcept C126322002 @default.
- W2169261617 hasConcept C126894567 @default.
- W2169261617 hasConcept C127413603 @default.
- W2169261617 hasConcept C141071460 @default.
- W2169261617 hasConcept C146357865 @default.
- W2169261617 hasConcept C146978453 @default.
- W2169261617 hasConcept C151730666 @default.
- W2169261617 hasConcept C19269812 @default.
- W2169261617 hasConcept C2776235491 @default.
- W2169261617 hasConcept C2777416452 @default.
- W2169261617 hasConcept C2777899217 @default.
- W2169261617 hasConcept C2778660094 @default.
- W2169261617 hasConcept C2779466945 @default.
- W2169261617 hasConcept C2780192828 @default.
- W2169261617 hasConcept C2781406297 @default.
- W2169261617 hasConcept C509974204 @default.
- W2169261617 hasConcept C71924100 @default.
- W2169261617 hasConcept C86803240 @default.
- W2169261617 hasConcept C88575799 @default.
- W2169261617 hasConceptScore W2169261617C121608353 @default.
- W2169261617 hasConceptScore W2169261617C126322002 @default.
- W2169261617 hasConceptScore W2169261617C126894567 @default.
- W2169261617 hasConceptScore W2169261617C127413603 @default.
- W2169261617 hasConceptScore W2169261617C141071460 @default.
- W2169261617 hasConceptScore W2169261617C146357865 @default.
- W2169261617 hasConceptScore W2169261617C146978453 @default.
- W2169261617 hasConceptScore W2169261617C151730666 @default.
- W2169261617 hasConceptScore W2169261617C19269812 @default.
- W2169261617 hasConceptScore W2169261617C2776235491 @default.
- W2169261617 hasConceptScore W2169261617C2777416452 @default.
- W2169261617 hasConceptScore W2169261617C2777899217 @default.
- W2169261617 hasConceptScore W2169261617C2778660094 @default.
- W2169261617 hasConceptScore W2169261617C2779466945 @default.
- W2169261617 hasConceptScore W2169261617C2780192828 @default.
- W2169261617 hasConceptScore W2169261617C2781406297 @default.
- W2169261617 hasConceptScore W2169261617C509974204 @default.
- W2169261617 hasConceptScore W2169261617C71924100 @default.
- W2169261617 hasConceptScore W2169261617C86803240 @default.
- W2169261617 hasConceptScore W2169261617C88575799 @default.
- W2169261617 hasIssue "1" @default.
- W2169261617 hasLocation W21692616171 @default.
- W2169261617 hasLocation W21692616172 @default.